Statistik Dasar
| LEI | 549300RFQ78SLDFSHF49 |
| CIK | 1803737 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Enhabit, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar kronologis Pengajuan SEC yang lengkap, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| May 26, 2026 |
15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in its |
|
| May 15, 2026 |
EX-99.1 Exhibit 99.1 Enhabit Completes Previously Announced Acquisition by Kinderhook Industries to Become a Private Company DALLAS and NEW YORK – May 15, 2026 - Enhabit, Inc. (“Enhabit” or the “Company”), a leading home health and hospice care provider, and Kinderhook Industries, LLC (“Kinderhook”), a middle market private equity firm, today announced the successful completion of the previously a |
|
| May 15, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): May 15, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation or organization) (Commiss |
|
| May 15, 2026 |
AMENDED AND RESTATED ENHABIT, INC. A Delaware Corporation May 15, 2026 ARTICLE I EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. A Delaware Corporation May 15, 2026 ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 1521 Concord Pike Suite 201, Wilmington Delaware 19803, in the County of New Castle. The name of the corporation’s registered agent at such address shall be United A |
|
| May 15, 2026 |
As filed with the Securities and Exchange Commission on May 15, 2026 As filed with the Securities and Exchange Commission on May 15, 2026 Registration No. |
|
| May 15, 2026 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ENHABIT, INC. ARTICLE I EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. ARTICLE I NAME The name of the corporation is Enhabit, Inc. (hereinafter called the “Corporation”). ARTICLE II PURPOSE The purpose for which the Corporation is organized is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware (the “DGCL”). T |
|
| May 15, 2026 |
As filed with the Securities and Exchange Commission on May 15, 2026 As filed with the Securities and Exchange Commission on May 15, 2026 Registration No. |
|
| May 12, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 12, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation |
|
| May 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to . Commission file number: 001-41406 Enhabit, Inc. (Exact |
|
| May 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 5, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabi |
|
| April 16, 2026 |
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook EX-99.1 Exhibit 99.1 Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook DALLAS, TX – April 16, 2026—Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the “Special Meeting”) on May 12, 2026, at 8 a.m. CDT, to vote on the previously |
|
| April 16, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): April 15, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation or organization) (Commi |
|
| April 14, 2026 |
DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2026 |
Table 1: Transaction Valuation Calculation of Filing Fee Tables Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee Rate Amount of Filing Fee Fees to be Paid 1 $ 751,593,926. |
|
| March 30, 2026 |
PREM14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| March 5, 2026 |
ENHABIT, INC. INSIDER TRADING POLICY (as amended and restated February 19, 2025) Exhibit 19.1 ENHABIT, INC. INSIDER TRADING POLICY (as amended and restated February 19, 2025) 1.Purpose and Scope. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Enhabit, Inc., a Delaware corporation (including its direct and indirect subsidiaries, the “Company” or “Enhabit”). The Company has adopted this Policy to promote complian |
|
| March 5, 2026 |
ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS Exhibit 10.12 ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Employees) Enhabit, Inc. (the “Company”) hereby grants to the Participant the number of Restricted Stock Units (“RSUs”) set forth below under the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan (the “Plan”). The RSUs are subject to all of the terms and conditions in this Notice of Grant of Restricted Stock Units (this |
|
| March 5, 2026 |
enhabitearningsxslidesx Fourth Quarter 2025 Supplemental Information March 4, 2026 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| March 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name |
|
| March 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 4, 2026 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| March 5, 2026 |
ENHABIT, INC. NOTICE OF GRANT OF PERFORMANCE-BASED RESTRICTED STOCK UNITS Exhibit 10.13 ENHABIT, INC. NOTICE OF GRANT OF PERFORMANCE-BASED RESTRICTED STOCK UNITS Enhabit, Inc. (the “Company”) hereby grants to the Participant the target number of performance-based Restricted Stock Units (“PRSUs”) set forth below under the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan (the “Plan”). The PRSUs are subject to all of the terms and conditions in this Notice of Gran |
|
| March 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 4, 2026 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| March 5, 2026 |
Enhabit Reports Fourth Quarter 2025 Financial Results Exhibit 99.1 Enhabit Reports Fourth Quarter 2025 Financial Results DALLAS, TX – March 4, 2026 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patie |
|
| March 5, 2026 |
Exhibit 21.1 Enhabit, Inc. Subsidiaries Name Jurisdiction A&B Home Health Solutions, LLC Delaware Abba Home Health, L.P. Texas Advanced Homecare Home Office, LLC Delaware Advanced Homecare Management, LLC Delaware AHM Action Home Health, LP Texas AHM Texas GP, LLC Delaware AHM Texas Holdings, Inc. Delaware AHM Texas LP, Inc. Delaware Apex Hospice LLC Texas Best Home Care LP Texas Camellia Home Hea |
|
| March 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 26, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpor |
|
| March 4, 2026 |
Execution Version AMENDED AND RESTATED CREDIT AGREEMENT dated as of February 26, 2026 among ENHABIT, INC. |
|
| February 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 24, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpor |
|
| February 26, 2026 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| February 23, 2026 |
EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among ENHABIT, INC., ANCHOR PARENT, LLC and ANCHOR MERGER SUB, INC. February 22, 2026 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2 Section 1.01 Definitions 2 Section 1.02 Other Definitional and Interpretative Provisions 15 ARTICLE 2 THE MERGER 16 Section 2.01 The Closing 16 Section 2.02 The Merger 16 Section 2.03 Conversion |
|
| February 23, 2026 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| February 23, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 22, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation or organization) (Co |
|
| February 23, 2026 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 22, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation or organizat |
|
| February 23, 2026 |
EX-99.1 Exhibit 99.1 Enhabit to be Acquired by Kinderhook Industries Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash DALLAS and NEW YORK – February 23, 2026 – Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC (“Kinderhook”), a middle market private e |
|
| February 23, 2026 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro |
|
| February 12, 2026 |
Exhibit 99.1 Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims for attorneys’ fees and mitigation damages in the Delaware Court of Chancery against former officer Ch |
|
| February 12, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 12, 2026 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpor |
|
| December 9, 2025 |
enhabitbofaconferencedec Bank of America Securities Home Care Conference Supplemental Information December 09, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| December 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 9, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 5, 2025 |
Exhibit 99.1 Enhabit Reports Third Quarter 2025 Financial Results Company to host a conference call tomorrow, November 6, 2025, at 9:00 a.m. EST DALLAS, TX – November 5, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. “Our third quarter results reflect strong execution on our co |
|
| November 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to . Commission file number: 001-41406 Enhabit, Inc. (E |
|
| November 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 5, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 5, 2025 |
enhabitearningsxslidesx Third Quarter Earnings Call Supplemental Information November 5, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| September 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 29, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpo |
|
| September 29, 2025 |
ehabjefferiesxhcxservic Jefferies Healthcare Services Conference Supplemental Information September 30, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to . Commission file number: 001-41406 Enhabit, Inc. (Exact |
|
| August 7, 2025 |
Exhibit 10.2 FORM OF ENHABIT, INC. RESTRICTED STOCK UNIT AGREEMENT Pursuant to the ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN (Directors) This Restricted Stock Unit Agreement (this “Agreement”) is made as of (the “Grant Date”), by Enhabit, Inc., a Delaware corporation (the “Corporation”), and the grantee named below (“Grantee”) pursuant to the ENHABIT, INC. 2025 EQUITY AND INCENTIVE |
|
| August 6, 2025 |
Form of Cash Retention Bonus Letter Agreement EX-10.3 Exhibit 10.3 ENHABIT, INC. , 2025 PERSONAL AND CONFIDENTIAL Dear []: This letter agreement (this “Agreement”) sets forth the terms and conditions pursuant to which Enhabit, Inc. (the “Company”) is offering you a retention bonus in the amount of $[] (the “Bonus”), including the eligibility requirements you must satisfy in order to receive the Bonus. You acknowledge and agree that the Compan |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 6, 2025 |
EX-10.2 Exhibit 10.2 ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Special Grant) Enhabit, Inc. (the “Company”) hereby grants to the Participant the number of Restricted Stock Units (“RSUs”) set forth below under the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan (the “Plan”). The RSUs are subject to all of the terms and conditions in this Notice of Grant of Restricted Stock |
|
| August 6, 2025 |
Exhibit 99.1 Enhabit Reports Second Quarter 2025 Financial Results Company Increases Full-Year 2025 Guidance Company to host a conference call tomorrow, August 7, 2025, at 10 a.m. EDT DALLAS, TX – August 6, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2025. “Our second quarter resu |
|
| August 6, 2025 |
enhabitearningsxslidesx Second Quarter Earnings Call Supplemental Information August 6, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| August 6, 2025 |
EX-99.1 Exhibit 99.1 Enhabit Home Health & Hospice Announces CEO Transition Plan Barb Jacobsmeyer to Step Down; Board Commencing Thorough Search for Successor DALLAS – August 6, 2025 — Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July |
|
| August 6, 2025 |
EX-10.1 Exhibit 10.1 Execution Version TRANSITION, SEPARATION AND RELEASE AGREEMENT Advanced Homecare Management, LLC d/b/a Enhabit Home Health & Hospice (the “Company”) and Barbara A. Jacobsmeyer (“Executive”) enter into this Transition, Separation and Release Agreement (this “Agreement”), which was received by Executive on the 1st day of August, 2025, signed by Executive on the 5th day of August |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| June 26, 2025 |
Enhabit, Inc. 2025 Equity Incentive Plan. Exhibit 10.1 ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN 1.Purpose. The purpose of this Plan is to permit the grant of awards to non-employee Directors, officers and other employees of the Company and its Subsidiaries, and certain consultants to the Company and its Subsidiaries, and to provide to such persons incentives and rewards for service and/or performance. 2.Definitions. Excep |
|
| June 26, 2025 |
Enhabit, Inc. 2025 Equity and Incentive Compensation Plan Exhibit 4.3 ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN 1.Purpose. The purpose of this Plan is to permit the grant of awards to non-employee Directors, officers and other employees of the Company and its Subsidiaries, and certain consultants to the Company and its Subsidiaries, and to provide to such persons incentives and rewards for service and/or performance. 2.Definitions. Except |
|
| June 26, 2025 |
Calculation of Filing Fee Tables S-8 Enhabit, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.01 per share Other 3,289,042 $ 9.28 $ 30,522,309.76 0.0001531 $ 4,672.97 Total Offering Amou |
|
| June 26, 2025 |
As filed with the Securities and Exchange Commission on June 26, 2025 As filed with the Securities and Exchange Commission on June 26, 2025 Registration No. |
|
| June 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 26, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| June 9, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 9, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation |
|
| June 9, 2025 |
Goldman Sachs 2025 Global Healthcare Conference June 10th, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 16, 2025 |
2024 Annual ReportUNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM10-K ☒ ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF 1934 ForthefiscalyearendedDecember31,2024 or ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACT OF1934 Forthetransitionperiodfromto Commissionfilenumber001-41406 Enhabit,Inc. (ExactnameofRegistrantasspecifiedinitscharte |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 7, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation) |
|
| May 7, 2025 |
Exhibit 99.1 Enhabit Reports First Quarter 2025 Financial Results Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT DALLAS, TX – May 7, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. “Enhabit’s first quarter 2025 results are a product of steadfast executio |
|
| May 7, 2025 |
First Quarter Earnings Call Supplemental Information May 8, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| May 2, 2025 |
PRELIMINARY COPY DATED MAY 2, 2025 – SUBJECT TO COMPLETION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabi |
|
| March 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 19, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| March 6, 2025 |
(incorporated by reference to Exhibit 21.1 Exhibit 21.1 Enhabit, Inc. Subsidiaries Name Jurisdiction A&B Home Health Solutions, LLC Delaware Abba Home Health, L.P. Texas Advanced Homecare Home Office, LLC Delaware Advanced Homecare Management, LLC Delaware AHM Action Home Health, LP Texas AHM Texas GP, LLC Delaware AHM Texas Holdings, Inc. Delaware AHM Texas LP, Inc. Delaware Apex Hospice LLC Texas Best Home Care LP Texas Camellia Home Hea |
|
| March 6, 2025 |
Enhabit, Inc. Insider Trading Policy, amended and restated, February 19, 2025 Exhibit 19.1 ENHABIT, INC. INSIDER TRADING POLICY (as amended and restated February 19, 2025) 1.Purpose and Scope. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Enhabit, Inc., a Delaware corporation (including its direct and indirect subsidiaries, the “Company” or “Enhabit”). The Company has adopted this Policy to promote complian |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name |
|
| March 5, 2025 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST DALLAS, TX – March 5, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. “Enhabit is exiting 2024 having executed specifi |
|
| March 5, 2025 |
Fourth Quarter Earnings Call Supplemental Information March 5, 2025 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 5, 2025 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| February 25, 2025 |
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors Exhibit 99.1 Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors DALLAS, TX – February 25, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit’s 2025 annual meeting of stockholders. Chairman of the Board Jeff Bolto |
|
| February 25, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpor |
|
| February 14, 2025 |
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of eHealth, Inc. |
|
| December 5, 2024 |
Investor Presentation December 10, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| December 5, 2024 |
Enhabit Announces Participation in Upcoming BofA Home Care Conference Exhibit 99.1 Enhabit Announces Participation in Upcoming BofA Home Care Conference DALLAS, TX – November 19, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference. Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan So |
|
| December 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 5, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| December 4, 2024 |
Exhibit 99.1 Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners BIRMINGHAM, ALA. & DALLAS, TX –December 4, 2024– On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by |
|
| December 4, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 4, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 14, 2024 |
EX-99.A 2 ex-a.htm JOINT FILING AGREEMENT Enhabit, Inc. SC 13G CUSIP No. 29332G102 13G Page 11 of 11 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of The Pennant Group, Inc., dated as of November 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall b |
|
| November 14, 2024 |
SC 13G 1 knots-sc13g111424.htm SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Enhabit, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2023 (Date of Event Which |
|
| November 8, 2024 |
Enhabit, Inc. Director Deferred Compensation Plan. Exhibit 10.2 ENHABIT, INC. DIRECTOR DEFERRED COMPENSATION PLAN Enhabit, Inc. hereby adopts, effective as of October 1, 2024, the Enhabit, Inc. Director Deferred Compensation Plan. The Plan provides Non-Employee Directors the opportunity to elect to receive Common Stock in lieu of Cash Compensation. The Plan also provides Non-Employee Directors the opportunity to defer payment of such Common Stock |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 7, 2024 |
Exhibit 10.3 ENHABIT, INC. RESTRICTIVE COVENANTS AGREEMENT This RESTRICTIVE COVENANTS AGREEMENT (“Agreement”) is entered into as of , 2024 (the “Effective Date”), by and between Advanced Homecare Management, LLC, on behalf of itself, and its current, past, and future parents, subsidiaries, and other corporate affiliates, and its or their successors or assigns (collectively referred to herein as “t |
|
| November 7, 2024 |
Exhibit 99.1 Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation DALLAS, TX – November 7, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next c |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 6, 2024 |
Exhibit 99.1 Enhabit Reports Third Quarter 2024 Financial Results Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST DALLAS, TX – November 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. “Our continued progress in our strategies during the third |
|
| October 7, 2024 |
EHAB / Enhabit, Inc. / BlackRock, Inc. Passive Investment SC 13G/A 1 us29332g1022100724.txt us29332g1022100724.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) Enhabit, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| October 4, 2024 |
EHAB / Enhabit, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 UnitedStates13GEnhabitInc.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* (Name of Issuer) Enhabit Inc (Title of Class of Securities) C |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 6, 2024 |
Second Quarter Earnings Call Supplemental Information August 7, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 6, 2024 |
Exhibit 99.1 Enhabit Reports Second Quarter 2024 Financial Results Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT DALLAS, TX – August 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. “The second quarter marked our third sequential quarter demonstrat |
|
| August 6, 2024 |
Enhabit Announces CFO Transition EX-99.1 3 a202408062024pressrelease.htm EX-99.1 Exhibit 99.1 Enhabit Announces CFO Transition DALLAS, TX – August 6, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles an |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 6, 2024 |
EX-10.1 2 separationandreleaseagreem.htm EX-10.1 Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT CRISSY B. CARLISLE (“you” or “Employee”) and Advanced Homecare Management, LLC d/b/a Enhabit Home Health & Hospice (the “Company”) enter into the following Separation and Release Agreement (“Agreement”) and acknowledge and agree as follows: 1.Your employment will terminate, without cause, effective at th |
|
| July 26, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 25, 2024 |
Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders Exhibit 99.1 Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders DALLAS—July 25, 2024— Enhabit, Inc. (NYSE: EHAB) (the “Company”), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit’s director nominees at the 2024 Annual Meeting of Stockholde |
|
| July 25, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 22, 2024 |
July 22, 2024 Fellow Stockholders, AREX Capital Management, LP (together with its affiliates, “AREX” or “we”) is the beneficial owner of approximately 4. |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confiden |
|
| July 15, 2024 |
Enhabit Releases Certain Preliminary Second Quarter 2024 Results Exhibit 99.1 Enhabit Releases Certain Preliminary Second Quarter 2024 Results DALLAS, July 15, 2024 – Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host |
|
| July 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 15, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 5, 2024 |
July 5, 2024 Fellow Stockholders, AREX Capital Management, LP and its affiliates (together, “AREX” or “we”) are collectively the beneficial owners of approximately 2. |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 27, 2024 |
Rehabilitate Enhabit Prepared by AREX Capital Management June 2024AREX Capital Disclaimer 2 The materials contained herein (the “Materials”) represent the opinions of AREX Capital Master Fund, LP and the other participants named in its proxy solicitation (collectively, “AREX” or “we”) and are based on publicly available information with respect to Enhabit Inc. |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 17, 2024 |
June 17, 2024 Fellow Stockholders, AREX Capital Management, LP (together with its affiliates, “AREX” or “we”) is the beneficial owner of approximately 4. |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 11, 2024 |
Goldman Sachs Global Healthcare Conference June 11th 2024 Enhabit Home Health & Hospice 1 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| June 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 10, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 10, 2024 |
2023 AnnualReportUNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM10-K ☒ ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACT OF1934 ForthefiscalyearendedDecember31,2023 or ☐TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGE ACTOF1934 Forthetransitionperiodfromto Commissionfilenumber001-41406 Enhabit,Inc. (ExactnameofRegistrantasspecifiedinitscharter |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| June 5, 2024 |
United States securities and exchange commission logo June 5, 2024 Andrew Freedman Partner, Olshan Frome Wolosky LLP Enhabit, Inc. |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| May 23, 2024 |
PRELIMINARY COPY DATED MAY 23, 2024 – SUBJECT TO COMPLETION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 8, 2024 |
Exhibit 99.1 Enhabit Reports First Quarter 2024 Financial Results Company to host a conference call tomorrow, May 9, 2024, at 10 a.m. EDT DALLAS, TX – May 8, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024. “Our momentum exiting 2023 and through the first quarter of 2024 instills |
|
| May 8, 2024 |
First Quarter Earnings Call Supplemental Information May 9, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 8, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation) |
|
| May 8, 2024 |
Exhibit 99.3 Enhabit Concludes Review of Strategic Alternatives Continues to Execute on Operating Plan; Commences Planned Board Transition DALLAS – May 8, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today announced Enhabit’s Board of Directors (the “Board”) has concluded the Company’s strategic review process, announced in August 2023, which was overseen by |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabi |
|
| April 4, 2024 |
United States securities and exchange commission logo April 4, 2024 Crissy Carlisle Chief Financial Officer Enhabit, Inc. |
|
| April 2, 2024 |
April 2, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Al Pavot Terence O’Brien Re: Enhabit, Inc. Form 10-K filed March 15, 2024 File No. 001-41406 Ladies and Gentlemen: Enhabit, Inc., a company incorporated under the laws of the state of Delaware (the “Compa |
|
| March 22, 2024 |
United States securities and exchange commission logo March 22, 2024 Crissy Carlisle Chief Financial Officer Enhabit, Inc. |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name |
|
| March 15, 2024 |
Exhibit 21.1 Enhabit, Inc. Subsidiaries Name Jurisdiction A&B Home Health Solutions, LLC Delaware Abba Home Health, L.P. Texas Advanced Homecare Management, LLC Delaware AHM Action Home Health, LP Texas AHM Texas GP, LLC Delaware AHM Texas LP, Inc. Delaware Apex Hospice LLC Texas Best Home Care LP Texas Camellia Home Health of Alabama, LLC Alabama Camellia Home Health of East Tennessee, LLC Delawa |
|
| March 15, 2024 |
Enhabit, Inc. Incentive Compensation Recoupment Policy, dated December 1, 2023 Exhibit 97.1 ENHABIT, INC. INCENTIVE COMPENSATION RECOUPMENT POLICY Effective December 1, 2023 1.Purpose. a.As required pursuant to the listing standards of the New York Stock Exchange (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Compensation and Human Capital Committee (the “Committee”) of t |
|
| March 15, 2024 |
Exhibit 2.3 SECOND AMENDMENT TO TRANSITION SERVICES AGREEMENT THIS SECOND AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is effective September 1, 2023 (the “Effective Date”), by and among Encompass Health Corporation, a Delaware corporation (the “Encompass Health”), and Enhabit, Inc., a Delaware corporation (“Enhabit”). RECITALS: WHEREAS, Encompass Health and Enhabit entered into t |
|
| March 6, 2024 |
Fourth Quarter Earnings Call Supplemental Information March 7, 2024 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| March 6, 2024 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance Company to host a conference call tomorrow, March 7, 2024, at 10 A.M. EST DALLAS, TX – March 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023. “Persistent focus on our Company’s strategie |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 6, 2024 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| February 13, 2024 |
EHAB / Enhabit, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0845-enhabitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Enhabit Inc Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pur |
|
| February 12, 2024 |
EHAB / Enhabit, Inc. / Flynn James E Passive Investment SC 13G/A 1 e619244sc13ga-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2023 |
|
| January 22, 2024 |
EHAB / Enhabit, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us29332g1022012224.txt us29332g1022012224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) Enhabit, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 3, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 7, 2023 |
Exhibit 99.1 Enhabit Reports Third Quarter 2023 Financial Results Revises Full-Year Guidance Company to host a conference call tomorrow, November 8, 2023 at 10 AM EDT DALLAS, TX – November 7, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2023. “In the midst of industry disruptio |
|
| November 7, 2023 |
Third Quarter Earnings Call Supplemental Information November 7, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| November 7, 2023 |
Exhibit 10.1 Execution Version SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of November 3, 2023 (this “Amendment”), is made among ENHABIT, INC., a Delaware corporation (the “Borrower”), the Subsidiaries party hereto (the “Subsidiary Guarantors” and, together with the Borrower, the “Loan Parties”), the Lenders (as defined below) party hereto and WELLS FAR |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 4, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporat |
|
| October 5, 2023 |
Exhibit 99.1 Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call Comments on Limited Waiver and Liquidity DALLAS, TX – Oct. 4, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters. The Company is in the |
|
| October 2, 2023 |
Exhibit 10.1 Execution Version LIMITED WAIVER THIS LIMITED WAIVER (this “Limited Waiver”), dated as of September 29, 2023, by and between Enhabit, Inc., a Delaware corporation (the “Borrower”), Wells Fargo Bank, National Association, as Administrative Agent for the Lenders (the “Administrative Agent”), and the undersigned Lenders. RECITALS WHEREAS, pursuant to the Credit Agreement, dated as of Jun |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 29, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpo |
|
| August 14, 2023 |
Exhibit 10.2 FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT THIS FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is effective June 30, 2023 (the “Effective Date”), by and among Encompass Health Corporation, a Delaware corporation (the “Encompass Health”), and Enhabit, Inc., a Delaware corporation (“Enhabit”). RECITALS: WHEREAS, Encompass Health and Enhabit entered into that c |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 9, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 9, 2023 |
enhabitearningsxslidesx Second Quarter Earnings Call Supplemental Information August 9, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 9, 2023 |
Exhibit 99.1 Enhabit Reports Second Quarter 2023 Financial Results Revises Full-Year Guidance Announces Intent to Launch Strategic Alternatives Process Subject to Satisfaction of Conditions in Tax Matters Agreement Company to host a conference call tomorrow, August 10, 2023 at 10 AM EDT DALLAS, TX – August 9, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 28, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| June 28, 2023 |
Exhibit 10.1 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of June 27, 2023 (this “Amendment”), is made among ENHABIT, INC., a Delaware corporation (the “Borrower”), the Subsidiaries party hereto (the “Subsidiary Guarantors” and, together with the Borrower, the “Credit Parties”), the lenders party hereto (the “Lenders”) and WELLS FARGO BAN |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| May 19, 2023 |
2022 AnnualReportUNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM10-K ☒ ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACT OF1934 Forthefi f fscalyearendedDecember31,2022 or ☐TRA R R NSITIONREPORTPURSUANTTOSECTION13OR15dOFTHESECURITIESEXCHANGEACT OF1934 Forthetransitionperiodfr f f omto Commissionfi f flenumber001-41406 Enhabit,Inc. (ExactnameofRegistrantasspeci |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number) |
|
| May 9, 2023 |
Exhibit 99.1 Enhabit Reports First Quarter 2023 Financial Results and Reaffirms Full-Year Guidance Announces new national payor agreement and two new convener agreements with national reach effective May 1, 2023 Company to host a conference call tomorrow, May 10, 2023 at 10 AM EDT DALLAS, TX – May 9, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported |
|
| May 9, 2023 |
enhabitearningsxslidesx First Quarter Earnings Call Supplemental Information May 10, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15d OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15d OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name o |
|
| April 14, 2023 |
Exhibit 99.1 CORRECTION—Enhabit, Inc. DALLAS, Texas, April 14, 2023 —This press release corrects a prior version published on February 14, 2023 and is updated to revise the Company’s previously disclosed financial results for the period ended December 31, 2022. The corrected release reads: Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance Company to host a conference call t |
|
| April 14, 2023 |
Enhabit, Inc. Insider Trading Policy, dated February 22, 2023. Exhibit 19.1 ENHABIT, INC. INSIDER TRADING POLICY 1.Purpose and Scope. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Enhabit, Inc., a Delaware corporation (including its direct and indirect subsidiaries, the “Company” or “Enhabit”). The Company has adopted this Policy to promote compliance with applicable laws that prohibit certai |
|
| April 14, 2023 |
Exhibit 10.6 ENHABIT, INC. NOTICE OF GRANT OF PERFORMANCE-BASED RESTRICTED STOCK UNITS Enhabit, Inc. (the “Company”) hereby grants to the Participant the target number of performance-based Restricted Stock Units (“PRSUs”) set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The PRSUs are subject to all of the terms and conditions in this Notice of Grant of |
|
| April 14, 2023 |
Exhibit 4.1 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a summary of the terms and provisions of the capital stock of Enhabit, Inc. (the “Company,” “we,” “our” and “us”), and is qualified in its entirety by reference to our amended and restated certificate of incorporation (the “Certificate of Incorporation”) and |
|
| April 14, 2023 |
Exhibit 10.5 ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Employees) Enhabit, Inc. (the “Company”) hereby grants to the Participant the number of Restricted Stock Units (“RSUs”) set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The RSUs are subject to all of the terms and conditions in this Notice of Grant of Restricted Stock Units (this “Gra |
|
| April 14, 2023 |
correctedenhabitearning Fourth Quarter Earnings Call Supplemental Information Initially published - February 14, 2023 / revised - April 14, 2023 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 |
|
| April 14, 2023 |
Exhibit 10.7 ENHABIT, INC. NOTICE OF GRANT OF NON-QUALIFIED STOCK OPTION (Employees) Enhabit, Inc. (the “Company”) hereby grants to the Participant an Option (the “Option”) to purchase the number of shares of Stock set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The Option is subject to all of the terms and conditions in this Notice of Grant of Non-Qua |
|
| April 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 |
|
| April 3, 2023 |
NT 10-K SEC FILE NUMBER 001-41406 CUSIP NUMBER 29332G102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2023 |
EX-99.1 Exhibit 99.1 Enhabit Announces Agreement with Cruiser Capital and Harbour Point Capital Board Appointments Support the Company’s Previously Announced Board Transition Plan DALLAS – March 30, 2023 – Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC (“Cruiser”) and Harbo |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 30, 2023 |
DEFA14A 1 d493395ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of |
|
| March 30, 2023 |
EX-10.1 Exhibit 10.1 COOPERATION AGREEMENT This COOPERATION AGREEMENT (this “Agreement”) is made and entered into as of March 30, 2023, by and among Enhabit, Inc., a Delaware corporation (the “Company”), Cruiser Capital Master Fund LP and Cruiser Capital Advisors, LLC (collectively with their Affiliates, “Cruiser”), and Harbour Point Capital Management LP (collectively with its Affiliates, “Harbou |
|
| February 28, 2023 |
ENHABIT, INC. EXECUTIVE CHANGE IN CONTROL BENEFITS PLAN (Amended and Restated as of February 22, 2023) Enhabit, Inc., a Delaware corporation (the “Company”), originally adopted the Enhabit, Inc. Change in Control Benefits Plan (the “Plan”) in connection with its separation from Encompass Health Corporation for the benefit of certain Participant employees of the Company and its subsidiaries. The Pl |
|
| February 28, 2023 |
ENHABIT, INC. EXECUTIVE SEVERANCE PLAN (Amended and Restated as of February 22, 2023) Enhabit, Inc., a Delaware corporation (the “Company”), originally adopted the Enhabit, Inc. Executive Severance Plan (the “Plan”) in connection with its separation from Encompass Health Corporation, for the benefit of certain employees of the Company and its subsidiaries. The Plan was originally effective July 1, |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 22, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Nu |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Nu |
|
| February 15, 2023 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance Company to host a conference call tomorrow, Feb. 15, 2023 at 10 AM EST DALLAS, TX – Feb. 14, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2022. “Significant changes were required in 2022 to l |
|
| February 10, 2023 |
EHAB / Enhabit Inc / BlackRock Inc. Passive Investment SC 13G/A 1 us29332g1022021023.txt us29332g1022021023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) ENHABIT, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| February 10, 2023 |
EHAB / Enhabit Inc / Flynn James E Passive Investment SC 13G/A 1 e618231sc13ga-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2022 |
|
| February 9, 2023 |
EHAB / Enhabit Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0821-enhabitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Enhabit Inc. Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pu |
|
| January 26, 2023 |
EHAB / Enhabit Inc / BlackRock Inc. Passive Investment SC 13G/A 1 us29332g1022012623.txt us29332g1022012623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ENHABIT, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| January 20, 2023 |
EHAB / Enhabit Inc / BlackRock Inc. Passive Investment SC 13G/A 1 us29332g1022012023.txt us29332g1022012023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) ENHABIT, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 14, 2022 |
Homecare Management, Inc. d/b/a Enhabit Home Health & Hosp Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT CHAD KNIGHT (“You” or “Employee”) and Advanced Homecare Management, Inc. d/b/a Enhabit Home Health & Hospice (the “Company”) enter into the following Separation and Release Agreement (“Agreement”) and acknowledge and agree as follows: 1. You have elected to resign your employment with the Company, and your employment will terminate effective close of b |
|
| November 14, 2022 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., November 9, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 1, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Num |
|
| November 2, 2022 |
Third Quarter Earnings Call Supplemental Information November 2, 2022 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| November 2, 2022 |
Exhibit 99.1 Enhabit Reports Third Quarter Financial Results Company to host a conference call tomorrow, Nov. 2, 2022 at 10 AM EDT DALLAS, TX ? Nov. 1, 2022 ? Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2022. ?We are making progress on our strategic initiatives,? Enhabit?s President |
|
| October 14, 2022 |
EHAB / Enhabit Inc / Flynn James E Passive Investment SC 13G 1 e622010sc13g-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. ) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) October 10, 2022 (Date |
|
| September 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 28, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File N |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 10, 2022 |
EHAB / Enhabit Inc / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv0011-enhabitinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Enhabit Inc. Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: July 29, 2022 Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| August 9, 2022 |
EHAB / Enhabit Inc / BlackRock Inc. Passive Investment SC 13G 1 us29332g1022080822.txt us29332g1022080822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) ENHABIT, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 29332G102 - (CUSIP Number) July 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| August 1, 2022 |
Second Quarter Earnings Call Supplemental Information August 2, 2022 Enhabit Home Health & Hospice 2 Forward Looking Statement Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 1, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Numbe |
|
| August 1, 2022 |
Exhibit 99.1 Investor Relations Contact Jennifer Hills 469-621-6496 [email protected] Media Contact Erin Volbeda 214.239.6520 [email protected] Enhabit Reports Second Quarter Financial Results Company to host a conference call tomorrow, Aug. 2, 2022 at 11 AM EDT DALLAS, TX ? Aug. 1, 2022 ? Enhabit Home Health & Hospice (NYSE: EHAB), a leading home health and hospice care provider, today |
|
| July 5, 2022 |
ENHABIT, INC. EXECUTIVE SEVERANCE PLAN Exhibit 10.3 ENHABIT, INC. EXECUTIVE SEVERANCE PLAN Enhabit, Inc., a Delaware corporation (the ?Company?), has adopted the Enhabit, Inc. Executive Severance Plan (the ?Plan?), to be effective as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation, for the benefit of certain employees of the Company and its |
|
| July 5, 2022 |
EX-3.1.2 7 ny20003604x14ex3-12.htm EXHIBIT 3.1.2 Exhibit 3.1.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as fo |
|
| July 5, 2022 |
Exhibit 2.4 EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. DATED AS OF JUNE 30, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01. Definitions 1 Section 1.02. Interpretation 6 ARTICLE II GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES 6 Section 2.01. General Principles 6 Section 2.02. Service Credit Recognized by Enhabit and Enhabit Benefit |
|
| July 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| July 5, 2022 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., July 1, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 Sect |
|
| July 5, 2022 |
EX-2.3 4 ny20003604x14ex2-3.htm EXHIBIT 2.3 Exhibit 2.3 TAX MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION and ENHABIT, INC. DATED AS OF JUNE 30, 2022 TABLE OF CONTENTS Page Section 1. Definition of Terms 2 Section 2. Allocation of Tax Liabilities 10 Section 2.01 General Rule 10 Section 2.02 Allocation of Federal Income Tax and Federal Other Tax 10 Section 2.03 Allocation of State I |
|
| July 5, 2022 |
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. EX-3.1.1 6 ny20003604x14ex3-11.htm EXHIBIT 3.1.1 Exhibit 3.1.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. Enhabit, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. This Certificate of Amendment (the “Certificate of A |
|
| July 5, 2022 |
Exhibit 2.2 TRANSITION SERVICES AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 ARTICLE II SERVICES, DURATION AND SERVICES MANAGERS 4 2.1 Services 4 2.2 Duration of Services 4 2.3 Additional Unspecified Services 5 2.4 Services Not Included 6 2.5 Transitional Nature of Services 6 2.6 Transition Services |
|
| July 5, 2022 |
Exhibit 10.1 ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the ?Plan?) is to promote the success, and enhance the value, of Enhabit, Inc. (the ?Company?) and its subsidiaries, by linking the personal interests of their employees, officers and directors to those of Company stockholders |
|
| July 5, 2022 |
Enhabit also announces two new appointments to its board of directors Exhibit 99.2 Enhabit Home Health & Hospice Completes Spin-off from Encompass Health Enhabit also announces two new appointments to its board of directors DALLAS ? July 1, 2022 ? Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporati |
|
| July 5, 2022 |
Exhibit 2.1 SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page SCHEDULES iii EXHIBITS iii ARTICLE I DEFINITIONS 2 ARTICLE II THE SEPARATION 13 2.1 Transfer of Assets and Assumption of Liabilities 13 2.2 Enhabit Assets; Encompass Assets 16 2.3 Enhabit Liabilities; Encompass Liabilities 18 2.4 Approvals |
|
| July 5, 2022 |
ENHABIT, INC. CHANGE IN CONTROL BENEFITS PLAN Exhibit 10.2 ENHABIT, INC. CHANGE IN CONTROL BENEFITS PLAN Enhabit, Inc., a Delaware corporation (the ?Company?), has adopted the Enhabit, Inc. Change in Control Benefits Plan (the ?Plan?), to be as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation for the benefit of certain Participant employees of the C |
|
| July 1, 2022 |
ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 Exhibit 4.3 ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the ?Plan?) is to promote the success, and enhance the value, of Enhabit, Inc. (the ?Company?) and its subsidiaries, by linking the personal interests of their employees, officers and directors to those of Company stockholders a |
|
| July 1, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Enhabit, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Aggregate Offering Price Per Share(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of registration fee(2) Equity Common Stock, p |
|
| July 1, 2022 |
As filed with the Securities and Exchange Commission on July 1, 2022 As filed with the Securities and Exchange Commission on July 1, 2022 Registration No. |
|
| July 1, 2022 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ENHABIT, INC. (a Delaware Corporation) Exhibit 4.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify as follows: 1. The name of the Corporation is Enhabit, I |
|
| July 1, 2022 |
Exhibit 4.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., July 1, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 Sect |
|
| June 21, 2022 |
INFORMATION STATEMENT ENHABIT, INC. TABLE OF CONTENTS Exhibit 99.1 ? June 21, 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a |
